Antithrombotic Therapy For Atrial Fibrillation

Authoring Organization

Publication Month/Year

August 1, 2018

Document Type


External Publication Status


Country of Publication


Document Objectives

The risk of stroke is heterogeneous across different groups of patients with atrial fibrillation (AF), being dependent on the presence of various stroke risk factors. We provide recommendations for antithrombotic treatment based on net clinical benefit for patients with AF at varying levels of stroke risk and in a number of common clinical scenarios.

Target Patient Population

Patients with atrial fibrillation

Inclusion Criteria

Female, Male, Adolescent, Adult, Older adult

Health Care Settings

Ambulatory, Hospital, Long term care, Outpatient

Intended Users

Nurse, nurse practitioner, physician, physician assistant


Assessment and screening, Prevention, Management, Treatment

Diseases/Conditions (MeSH)

D001281 - Atrial Fibrillation, D011315 - Preventive Medicine, D020521 - Stroke, D011655 - Pulmonary Embolism, D012307 - Risk Factors


atrial fibrillation, risk factors, prevention, anticoagulation, stroke, Stroke Prevention, Antithrombotic Agents, Anticoagulation


Number of Source Documents
Literature Search Start Date
January 1, 2007
Literature Search End Date
October 1, 2017